The role of tumor molecular subtypes in formation of personalized approach to the theatment of the breast cancer

Journal Title: Медичні перспективи - Year 2016, Vol 21, Issue 2

Abstract

Extreme heterogeneity of breast cancer (BC) is considered to be one of the reasons that affects the success of treatment. According to current classifications, there are 4 molecular subtypes (MS). The basis for subtypes division is immunohistochemical testing of tumor cell receptors - estrogen (ER), progesterone (PR), HER2-neu and Ki-67. The doctrine of the tumor MS was the basis for the individualization of therapeutic tactics in patients with breast cancer. It was studied that luminal A subtype is the most common and the most favorable, with hormone therapy being a highly effective treatment method. Luminal B subtype, HER2 - positive and triple negative MS is characterized by a high ag­gressiveness, worse survival rate of patients and better prognostic effect of chemotherapy. The importance of determining the level of Ki-67 for assessment of tumor aggressiveness was revealed. Significant differences in receptor status of the primary tumor and metastases were proven. Data on the impact of changes in receptor status of the tumor prognosis are ambiguous and need further study. The use of targeted agents in the treatment of HER2 + patients can significantly improve treatment outcomes, turning this MS from historically aggressive subgroup to quite favorable.

Authors and Affiliations

I. Bondarenko , Elhajj Mohammad H. , K. Chebanov , A. Phokhach , Y. Bondarenko

Keywords

Related Articles

Relationship between the body mass indices and gender belonging and the severity of received damages in combined body injuries

On the clinical material of 107 patients with combined body injury there was found the typical peculiarities of the damage depending on the value of the body mass index (BMI) and gender. The obtained results showed that...

Determining level of endogenous serum erythropoietin for differential diagnosis of polycythemia vera and symptomatic polycythemia 

The article deals with determining possibility of the assessment of the level of endogenous serum erythropoietin (EPO) for differential diagnosis of polycythemia vera (PV) and secondary erythrocytosis (SE). The determina...

Прогнозування розвитку гострих отруєнь у сільскогосподарських робітників при використанні комбінованих препаратів на основі дифеноконазолу

Прогнозирование развития острых отравлений у сельскохозяйственных рабочих при использовании комбинированных препаратов на основе дифеноконазола. Ставниченко П.В., Антоненко А.Н., Бардов В.Г. В общей структуре профзаболев...

Download PDF file
  • EP ID EP101596
  • DOI -
  • Views 128
  • Downloads 0

How To Cite

I. Bondarenko, Elhajj Mohammad H. , K. Chebanov, A. Phokhach, Y. Bondarenko (2016). The role of tumor molecular subtypes in formation of personalized approach to the theatment of the breast cancer. Медичні перспективи, 21(2), 81-86. https://europub.co.uk/articles/-A-101596